About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Nashville | 291 Studies

Clinical Trials Pancreatic CancerNashville

Pancreatic Cancer Clinical Trials in Nashville

Find 291 clinical trials for pancreatic cancer near Nashville, Tennessee. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Nashville

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 201-220 of 291 trials

CompletedDose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLCThis study is a Phase I, first in human, dose-escalation study of MORAb-066, an investigational humanized immunoglobulin G (IgG) monoclonal antibody (mAb) that targets…NCT01761240·Oklahoma City, Oklahoma and 1 other RecruitingZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsThe primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or…NCT06943755·Birmingham, Alabama and 134 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingIncreasing Germline Genetic Testing for Patients With CancerGermline testing for hereditary cancer syndromes is underutilized across most health care settings.NCT07307664·Los Angeles, California and 9 others

TerminatedInternal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine TumorsRATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.NCT00466856·Nashville, Tennessee

CompletedPhase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid TumorsThis is a Phase 1 open-label study of SN2310 Injectable Emulsion in patients with advanced solid malignancies.NCT00385177·Philadelphia, Pennsylvania and 1 other

TerminatedTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsThis is a subprotocol of Master Protocol DAY101-102 and is a Phase 1b/2, multi-center, open label subprotocol of participants ≥12 years of age, with recurrent or progressive solid…NCT07121829·Los Angeles, California and 9 others

RecruitingStudy of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic CancerThe study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in subjects…NCT05254171·Hot Springs, Arkansas and 92 others

TerminatedA Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic MalignanciesThe purpose of this study is to learn about the safety and the effects of PF-08046037 alone or with sasanlimab for the treatment of certain advanced or metastatic malignancies.NCT06974734·Denver, Colorado and 14 others

CompletedDose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic CancerThis is an open-label Phase 1b dose-escalation study to assess the safety, tolerability, and PK of OMP-54F28 when combined with nab-paclitaxel and gemcitabine.NCT02050178·Los Angeles, California and 4 others

CompletedErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerThis phase I trial is studying the side effects and best dose of erlotinib hydrochloride when given together with cetuximab and to see how well they work in treating patients with…NCT00397384·Nashville, Tennessee

CompletedEffects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid TumorsThis is a Phase I study to test the safety, pharmacokinetics and effectiveness of STM 434 alone, or in combination with liposomal doxorubicin, in patients with ovarian cancer or…NCT02262455·Boston, Massachusetts and 3 others

UnknownEfficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic AdenocarcinomaThis study evaluates the efficacy and safety of PBI-05204, an extract of the leaves of Nerium oleander, in patients with Stage IV metastatic pancreatic cancer.NCT02329717·Scottsdale, Arizona and 4 others

CompletedPhase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid TumorsThe key purpose of the main part of the study is to assess efficacy and safety of anetumab ravtansine as monotherapy or combination therapy for mesothelin expressing advanced…NCT03102320·Phoenix, Arizona and 71 others

CompletedS1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryThis randomized phase II trial studies how well fluorouracil, irinotecan hydrochloride, and oxaliplatin (combination chemotherapy) works and compares to gemcitabine hydrochloride…NCT02562716·Birmingham, Alabama and 806 others

CompletedCovered vs Uncovered Metal Stents for Palliative Biliary Decompression in Inoperable Malignant Distal Bile Duct ObstructionThe purpose of this study is to compare the rate of long-term stent failure, defined as need for repeat biliary intervention following placement of C-SEMS vs U-SEMS for palliation…NCT01905384·New York, New York and 1 other

CompletedA Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid TumorsThe purpose of this study is to confirm the safety and tolerability of TAK-931 in a cohort of Western participants with metastatic solid tumors and to evaluate the anti-tumor…NCT03261947·Denver, Colorado and 9 others

CompletedSelumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With ChemotherapyThis randomized phase II trial studies how well selumetinib and Akt inhibitor MK2206 work compared to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) therapy…NCT01658943·Tucson, Arizona and 533 others

CompletedFOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic CancerThis randomized phase II trial studies how well modified irinotecan hydrochloride, leucovorin calcium, fluorouracil (FOLFIRI) and veliparib as a second line of therapy work…NCT02890355·Mobile, Alabama and 782 others

CompletedCombination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the PancreasRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more that one drug may kill more tumor cells.NCT00003810·Indianapolis, Indiana and 9 others

RecruitingStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsThis is an open label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, MTD PK, and PD of TJ033721 (givastomig) in subjects with advanced or…NCT04900818·Orange, California and 20 others

PreviousPage 11 of 15Next

Other Conditions in Nashville

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia